Urgent funding appeal for ACT-Accelerator

2021-08-17T10:35:00+01:00By Rob Cockerill, Global Managing Editor

With more Covid-19 cases reported in the first five months of 2021 than in the whole of 2020 and the fear that hard-won gains of the last three months are at risk, the ACT-Accelerator has mounted a $7.7bn funding appeal, including $1.2bn to rapidly address acute oxygen needs.